This case concerns the merger notification of the appellant in connection with the transaction between Faxa ehf., which controls the appellant, and Lyfjavals ehf. pursuant to a purchase agreement dated 26 April 2022, and an alleged discrepancy by the merging parties in the description of the contents of the purchase agreement. The contested decision of the Competition Council of 2 March 2023 to discontinue its merger investigation, which was originally based on the appellant's merger notification, dated The decision of the Competition Authority of 2 March 2023 to discontinue its merger investigation, which was originally based on the merger notification submitted by the appellant on 5 August 2022, was not in accordance with the provisions of the Competition Act No. 44/2005 and is therefore set aside. The Competition Authority is ordered to complete the merger investigation in accordance with the provisions of the Competition Act.
2 / 2023
Medicine and Health Ltd.
"*" indicates required fields